Source comparison
Comparison: Melanotan-1 vs Other EPP Management Strategies
Afamelanotide (Scenesse) MC1R agonist → increased eumelanin production 50–200% increase in pain-free sun exposure (median 69.4% vs 4.8% placebo in CUV029) 60–90 days per implant (requires 3–4 annual doses) FDA-approved but REMS-restricted; ~$20,000–$30,000 per
This comparison does not assign a generated winner or score.
- Afamelanotide (Scenesse)
- MC1R agonist → increased eumelanin production
- 50–200% increase in pain-free sun exposure (median 69.4% vs 4.8% placebo in CUV029)
- 60–90 days per implant (requires 3–4 annual doses)
- FDA-approved but REMS-restricted; ~$20,000–$30,000 per implant in U.S.; limited insurance coverage
- Most effective pharmacological option for extending tolerable light exposure; response varies by baseline phototype
- Beta-carotene supplementation
- Antioxidant scavenging of singlet oxygen
- Minimal to no measurable photoprotection in controlled trials; patient-reported benefit inconsistent
- Continuous (daily oral)
- Over-the-counter; $10–$30/month
- Widely used historically but lacks robust clinical evidence; may provide marginal benefit in subset of patients
- Strict light avoidance
- Behavioural. Prevent protoporphyrin excitation
- 100% effective at preventing phototoxic reactions when complete
- Continuous
- No cost
- Gold standard for symptom prevention but severely impacts quality of life; not sustainable for most patients
- Red blood cell transfusions
- Dilute protoporphyrin concentration in circulation
- Transient reduction in phototoxicity for 4–6 weeks post-transfusion
- 4–6 weeks
- Hospital-based; requires matching, monitoring for iron overload
- Reserved for severe cases or planned high-exposure events (e.g., weddings, vacations); not viable long-term
- Cysteine and N-acetylcysteine
- Antioxidant support
- No clinical trial evidence of photoprotection; theoretical mechanism only
- Over-the-counter; $15–$40/month
- Lacks evidence base; popular in patient communities but not recommended by clinical guidelines